anti-GITR antibodies (Regeneron/Sanofi)

N/A

Report date: 2025/03/14 20:00:48

Base Information

Drug Nameanti-GITR antibodies (Regeneron/Sanofi)
Drug Alias NameGITR costimulator (Regeneron/Sanofi)
ClassificationBiologics > Protein drugs > Immunoglobulin > Antibody
Mechanisms of ActionGlucocorticoid-induced tumor necrosis factor receptor-related protein agonists
TargetsGlucocorticoid-induced tumor necrosis factor receptor-related protein
Therapy Area/IndicationsNeoplasms
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryUnited StatesFrance
CombinationsNo
Global Highest StatusPending (Preclinical)
Highest Status in ChinaN/A
Originator CompaniesRegeneron Pharmaceuticals Inc
China Registration ClassN/A

Develop Information

Active CompaniesN/A
Inactive CompaniesSanofiRegeneron Pharmaceuticals Inc
Active IndicationsN/A
Inactive IndicationsNeoplasms

Other Information

ATC CodeN/A
Related LinksN/A